SOCS2 and prostate carcinoma: CSR3/SOCS2-AS1, located in the genome antisense to the Suppressor of Cytokine Signaling-2 (SOCS2) gene, is induced by androgen receptor signaling in prostate cancer cells and promotes androgen-dependent cell growth (Misawa et al., 2016).